Skip to main content

Ulcerative Colitis Treatment

Ulcerative colitis is treated mainly with various types of medication that can reduce inflammation and give the intestines a chance to heal. There are also surgical and diet treatment options available:

How is ulcerative colitis treated?

Medication

Ulcerative colitis is treated mainly with various types of medication that can reduce inflammation and give the intestines a chance to heal. Often, the same medications will be used in treat a flare-up and preventing symptoms during remission, but will usually be administered in different dosages and schedules.

Surgery

Some people might require surgery to remove all or parts of the colon and/or to treat the complications that might arise with ulcerative colitis.

Ulcerative Colitis Diet

The onset of ulcerative colitis is not thought to be related to diet, but proper diet and nutrition are very important in the management of the condition.

X-Rays and Endoscopy Procedures

Although x-rays and endoscopy procedures are generally kept to a minimum for those diagnosed with Ulcerative colitis, it is likely they will need to be repeated from time to time to determine success after surgery or, more routinely:

  • to check on the extent of the inflammation
  • to see if there are any changes in tissues (e.g., development of pre-cancerous cells)
  • to determine whether on not a particular treatment strategy is working. Endoscopy is usually performed under local anaesthetic or sedation.

 

Additional Information:

The latest news and Research

News

Gutsy effort to produce comprehensive study of intestinal gases

Posted: September 18 2019

A source of embarrassment to some, or pure comedy to others, flatulence and the gases of the intestines are increasingly seen as playing an important role in our digestive health. A paper led by UNSW Sydney and published in Nature Reviews Gastroenterology & Hepatology has examined all available literature on gastrointestinal gases, their interactions with the microbiome […]

Read more

News

Putting an end to inflammation

Posted: September 18 2019

Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has succeeded in securing research funding in one of the toughest European selection processes. Over the next five years, the European Research Council (ERC) will support his outstanding research project with an ERC Starting Grant of 1.5 million euros. Dr. Andreas Ramming from the Department of Medicine […]

Read more

Research

Scientists discover promising new lead in Crohn’s disease

QIMR Berghofer researchers have identified a key driver of the aggressive gut disorder, Crohn’s disease, a finding that could eventually lead to new treatments for the often-debilitating condition.

Crohn’s disease – also known as inflammatory bowel disease – is incurable and affects about 35,000 people in Australia. QIMR Berghofer scientists found the protein PD-L2 was overactive in people with Crohn’s disease. The study was led by the head of the Molecular Immunology group, Dr Michelle Wykes, and Dr Graham Radford-Smith, who leads the […]

Read more

Personal Story

Student with stoma accused of taking drugs

Posted: September 11 2019

Amber Davies, 21, from Builth Wells, has a stoma after being diagnosed with ulcerative colitis aged 13. While on a night out in Birmingham, she was “grabbed” by a bouncer after coming out of the disabled toilet. Wetherspoons said staff apologised for the “confusing situation”. Amber posted an open letter on her Instagram account detailing her experience, saying the […]

Read more

Research

Diet-induced remission of Crohn’s disease associated with altered microbial community structure

Researchers from the University of Pennsylvania looked at the association of diet, gut microbiome and IBD.

Background The microbiome has been implicated in the initiation and persistence of inflammatory bowel disease. Despite the fact that diet is one of the most potent modulators of microbiome composition and function and that dietary intervention is the first-line therapy for treating pediatric Crohn’s disease, the relationships between diet-induced remission, enteropathy, and microbiome are poorly […]

Read more

News

Serotonin and anti-depressants can have a major effect on the gut’s microbiota

Posted: September 11 2019

Serotonin — a neurotransmitter, or chemical messenger that sends messages among cells — serves many functions in the human body, including playing a role in emotions and happiness. An estimated 90% of the body’s serotonin is produced in the gut, where it influences gut immunity. The team — led by senior author Elaine Hsiao and […]

Read more